ArticleDrug testing and analysis2026
Comparing the Stability and Detectability of Testosterone Esters in Capillary Serum, Sodium Fluoride-Containing Plasma, and Dried Blood Spots After Testosterone Ester Administration.
Article in Drug testing and analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Steroid esters are a frequently used ergogenic aid among athletes, and their direct detection represents an important approach to anti-doping efforts. However, the presence of esterase enzymes in blood complicates these efforts. Although dried blood spots (DBS) have emerged as a promising solution to the esterase problem, the limited sample volume creates both analytical and practical challenges. The larger collection volume for liquid blood may allow for higher analytical sensitivity, thus offsetting the effects of esterase activity in practical scenarios. First, to evaluate the effects of blood esterases ex vivo, 10 individuals were administered a single dose of either testosterone propionate or testosterone cypionate. Venous blood was collected into serum separator tubes (SST) serum and NaF-containing tubes and stored at varying conditions. Both esters significantly decreased in serum while no ester loss was observed in the NaF-containing plasma. Next, to compare the detectability across matrices stored at conditions meant to mimic real-world scenarios, the individuals administered testosterone propionate collected capillary serum, capillary NaF-containing plasma, and capillary DBS at various times postadministration. Each sample type was stored at different conditions designed to mimic what may be encountered during real-world shipping scenarios. Similar detectability of testosterone propionate was observed between all NaF, DBS, and SST samples stored under cool conditions, whereas detectability was better in NaF and DBS samples under ambient and warm conditions. These results indicate that for samples not shipped in temperature regulated conditions, DBS and NaF-containing plasma are the preferred matrices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.